Modulation of VEGF signaling in a mouse model of diabetes by xanthohumol and 8-prenylnaringenin: Unveiling the angiogenic paradox and metabolism interplay

Molecular Nutrition and Food Research

Volumn 61, Issue 4, 2017, Pages

  Costa, Raquel ^a,b   Rodrigues, Ilda ^a   Guardão, Luísa ^a   Lima, Joana Quelhas ^c   Sousa, Emília ^c,d   Soares, Raquel ^a,b   Negrão, Rita ^a,b  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

8 Prenylnaringenin; Angiogenesis; Bifunctional enzyme; Lipid uptake; Xanthohumol

Indexed keywords

8-PRENYLNARINGENIN; ANGIOGENIC FACTOR; FLAVANONE DERIVATIVE; FLAVONOID; FLT1 PROTEIN, HUMAN; POLYPHENOL; PROPIOPHENONE DERIVATIVE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; XANTHOHUMOL;

ANIMAL; DIABETIC COMPLICATION; DISEASE MODEL; HUMAN; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NON INSULIN DEPENDENT DIABETES MELLITUS; SIGNAL TRANSDUCTION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FLAVANONES; FLAVONOIDS; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; POLYPHENOLS; PROPIOPHENONES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 85011031752     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600488     Document Type: Article

References (60)

1. Blake, R., Trounce, I. A., Mitochondrial dysfunction and complications associated with diabetes. Biochim. Biophys. Acta. 2014, 1840, 1404–1412.
2. Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813–820.
3. Schnuelle, P., Benck, U., Kramer, B. K., Erythropoietin in kidney disease and type 2 diabetes. N. Engl. J. Med. 2011, 364, 384; author reply 385–386.
4. Soares, R., Costa, C., Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome, Springer, New York 2009.
5. De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A. et al., Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 2013, 154, 651–663.
6. Zecchin, A., Stapor, P. C., Goveia, J., Carmeliet, P., Metabolic pathway compartmentalization: an underappreciated opportunity? Curr. Opin. Biotechnol. 2015, 34, 73–81.
7. Eichmann, A., Simons, M., Need glucose to sprout: local metabolic control of angiogenesis. EMBO Mol. Med. 2013, 5, 1459–1461.
8. Van Schaftingen, E., Lederer, B., Bartrons, R., Hers, H. G., A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur. J. Biochem. 1982, 129, 191–195.
9. Schoors, S., De Bock, K., Cantelmo, A. R., Georgiadou, M. et al., Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis. Cell Metab. 2014, 19, 37–48.
10. Roskoski, R., Jr., Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit. Rev. Oncol. Hematol. 2007, 62, 179–213.
11. Koch, S., Tugues, S., Li, X., Gualandi, L. et al., Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 2011, 437, 169–183.
12. Waltenberger, J., VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus. Biochem. Soc. Trans. 2009, 37, 1167–1170.
13. Ferrara, N., Kerbel, R. S., Angiogenesis as a therapeutic target. Nature 2005, 438, 967–974.
14. Robinson, C. J., Stringer, S. E., The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 2001, 114, 853–865.
15. Rahimi, N., Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials. Exp. Eye. Res. 2006, 83, 1005–1016.
16. Li, X., VEGF-B: a thing of beauty. Cell. Res. 2010, 20, 741–744.
17. Bry, M., Kivela, R., Holopainen, T., Anisimov, A. et al., Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation 2010, 122, 1725–1733.
18. Hagberg, C. E., Falkevall, A., Wang, X., Larsson, E. et al., Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 2010, 464, 917–921.
19. Hagberg, C., Mehlem, A., Falkevall, A., Muhl, L. et al., Endothelial fatty acid transport: role of vascular endothelial growth factor B. Physiology (Bethesda) 2013, 28, 125–134.
20. Muhl, L., Moessinger, C., Adzemovic, M. Z., Dijkstra, M. H. et al., Expression of vascular endothelial growth factor (VEGF)-B and its receptor (VEGFR1) in murine heart, lung and kidney. Cell Tissue Res. 2016, 365, 51–63.
21. Carmeliet, P., Wong, B. W., De Bock, K., Treating diabetes by blocking a vascular growth factor. Cell Metab. 2012, 16, 553–555.
22. Imhof, A., Woodward, M., Doering, A., Helbecque, N. et al., Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur. Heart. J. 2004, 25, 2092–2100.
23. Vinson, J. A., Mandarano, M., Hirst, M., Trevithick, J. R. et al., Phenol antioxidant quantity and quality in foods: beers and the effect of two types of beer on an animal model of atherosclerosis. J. Agric. Food Chem. 2003, 51, 5528–5533.
24. Nozawa, H., Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice. Biochem. Biophys. Res. Commun. 2005, 336, 754–761.
25. Gerhauser, C., Beer constituents as potential cancer chemopreventive agents. Eur. J. Cancer. 2005, 41, 1941–1954.
26. Legette, L., Ma, L., Reed, R. L., Miranda, C. L. et al., Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration. Mol. Nutr. Food Res. 2012, 56, 466–474.
27. Rosell, M. S., Hellenius, M. L., de Faire, U. H., Johansson, G. K., Associations between diet and the metabolic syndrome vary with the validity of dietary intake data. Am. J. Clin. Nutr. 2003, 78, 84–90.
28. Scoditti, E., Calabriso, N., Massaro, M., Pellegrino, M. et al., Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch. Biochem. Biophys. 2012, 527, 81–89.
29. Nikolic, D., Li, Y., Chadwick, L. R., van Breemen, R. B., In vitro studies of intestinal permeability and hepatic and intestinal metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops (Humulus lupulus L.). Pharm. Res. 2006, 23, 864–872.
30. Possemiers, S., Rabot, S., Espin, J. C., Bruneau, A. et al., Eubacterium limosum activates isoxanthohumol from hops (Humulus lupulus L.) into the potent phytoestrogen 8-prenylnaringenin in vitro and in rat intestine. J. Nutr. 2008, 138, 1310–1316.
31. Possemiers, S., Verstraete, W., Oestrogenicity of prenylflavonoids from hops: activation of pro-oestrogens by intestinal bacteria. Environ Microbiol Rep 2009, 1, 100–109.
32. Negrao, R., Costa, R., Duarte, D., Taveira Gomes, T. et al., Angiogenesis and inflammation signaling are targets of beer polyphenols on vascular cells. J. Cell. Biochem. 2010, 111, 1270–1279.
33. Bobak, M., Skodova, Z., Marmot, M., Beer and obesity: a cross-sectional study. Eur. J. Clin. Nutr. 2003, 57, 1250–1253.
34. Kiyofuji, A., Yui, K., Takahashi, K., Osada, K., Effects of xanthohumol-rich hop extract on the differentiation of preadipocytes. J. Oleo Sci. 2014, 63, 593–597.
35. Legette, L., Karnpracha, C., Reed, R. L., Choi, J. et al., Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops. Mol. Nutr. Food Res. 2014, 58, 248–255.
36. Yui, K., Kiyofuji, A., Osada, K., Effects of xanthohumol-rich extract from the hop on fatty acid metabolism in rats fed a high-fat diet. J. Oleo Sci. 2014, 63, 159–168.
37. Miranda, C. L., Elias, V. D., Hay, J. J., Choi, J. et al., Xanthohumol improves dysfunctional glucose and lipid metabolism in diet-induced obese C57BL/6J mice. Arch. Biochem. Biophys. 2016, 599, 22–30.
38. Sumiyoshi, M., Kimura, Y., Hop (Humulus lupulus L.) extract inhibits obesity in mice fed a high-fat diet over the long term. Br. J. Nutr. 2013, 109, 162–172.
39. Gorinstein, S., Caspi, A., Libman, I., Leontowicz, H. et al., Bioactivity of beer and its influence on human metabolism. Int. J. Food Sci. Nutr. 2007, 58, 94–107.
40. Cederroth, C. R., Nef, S., Soy, phytoestrogens and metabolism: a review. Mol. Cell Endocrinol. 2009, 304, 30–42.
41. Andreoli, M. F., Stoker, C., Rossetti, M. F., Alzamendi, A. et al., Withdrawal of dietary phytoestrogens in adult male rats affects hypothalamic regulation of food intake, induces obesity and alters glucose metabolism. Mol. Cell Endocrinol. 2015, 401, 111–119.
42. Llaneza, P., Gonzalez, C., Fernandez-Inarrea, J., Alonso, A. et al., Soy isoflavones, Mediterranean diet, and physical exercise in postmenopausal women with insulin resistance. Menopause 2010, 17, 372–378.
43. Zierau, O., Gester, S., Schwab, P., Metz, P. et al., Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin. Planta Med. 2002, 68, 449–451.
44. Costa, R., Negrao, R., Valente, I., Castela, A. et al., Xanthohumol modulates inflammation, oxidative stress, and angiogenesis in type 1 diabetic rat skin wound healing. J. Nat. Prod. 2013, 76, 2047–2053.
45. Negrao, R., Costa, R., Duarte, D., Gomes, T. T. et al., Xanthohumol-supplemented beer modulates angiogenesis and inflammation in a skin wound healing model. Involvement of local adipocytes. J. Cell. Biochem. 2012, 113, 100–109.
46. Cong, W. N., Tao, R. Y., Tian, J. Y., Liu, G. T. et al., The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. Life Sci. 2008, 82, 983–990.
47. Legette, L. L., Luna, A. Y., Reed, R. L., Miranda, C. L. et al., Xanthohumol lowers body weight and fasting plasma glucose in obese male Zucker fa/fa rats. Phytochemistry 2013, 91, 236–241.
48. Wirostko, B., Wong, T. Y., Simo, R., Vascular endothelial growth factor and diabetic complications. Prog. Retin. Eye Res. 2008, 27, 608–621.
49. Kerimi, A., Williamson, G., At the interface of antioxidant signalling and cellular function: key polyphenol effects. Mol. Nutr. Food Res. 2016, 60, 1770–1788.
50. Carneiro, A. M., Costa, R., Falcao, M. S., Barthelmes, D. et al., Vascular endothelial growth factor plasma levels before and after treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumab. Acta Ophthalmol. 2012, 90, e25–30.
51. Zakareia, F. A., Correlation of peripheral arterial blood flow with plasma chemerin and VEGF in diabetic peripheral vascular disease. Biomark. Med. 2012, 6, 81–87.
52. Yoon, Y. S., Uchida, S., Masuo, O., Cejna, M. et al., Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 2005, 111, 2073–2085.
53. Soares, R., Guo, S., Gartner, F., Schmitt, F. C. et al., 17 beta -estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk. Angiogenesis 2003, 6, 271–281.
54. Soares, R., Guo, S., Russo, J., Schmitt, F., Role of the estrogen antagonist ICI 182,780 in vessel assembly and apoptosis of endothelial cells. Ultrastruct. Pathol. 2003, 27, 33–39.
55. Konner, A. C., Bruning, J. C., Selective insulin and leptin resistance in metabolic disorders. Cell Metab. 2012, 16, 144–152.
56. Cerezo, A. B., Winterbone, M. S., Moyle, C. W., Needs, P. W. et al., Molecular structure-function relationship of dietary polyphenols for inhibiting VEGF-induced VEGFR-2 activity. Mol. Nutr. Food Res. 2015, 59, 2119–2131.
57. Moyle, C. W., Cerezo, A. B., Winterbone, M. S., Hollands, W. J. et al., Potent inhibition of VEGFR-2 activation by tight binding of green tea epigallocatechin gallate and apple procyanidins to VEGF: relevance to angiogenesis. Mol. Nutr. Food Res. 2015, 59, 401–412.
58. Heilbronn, L., Smith, S. R., Ravussin, E., Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int. J. Obes. Relat. Metab. Disord. 2004, 28(Suppl 4), S12–21.
59. Costanzo, A. E., Taylor, K. R., Dutt, S., Han, P. P. et al., Obesity impairs gammadelta T cell homeostasis and antiviral function in humans. PLoS One 2015, 10, e0120918.
60. Villena, J. A., Kralli, A., ERRalpha: a metabolic function for the oldest orphan. Trends Endocrinol. Metab. 2008, 19, 269–276.